Advancing Efficient GPCR Drug Discovery via Computational Methods

webinar

Thu, 27 Mar 2025, 16:00 CET (Berlin)

Prof. Dr. Shuguang Yuan, Shenzhen University of Advanced Technology, Chinese Academy of Sciences, China

Advancing Efficient GPCR Drug Discovery via Computational Methods

Modern drug discovery is a long and tedious process which takes, on average, at least 10 years and 2 billion USD to bring a drug to market. One of the most critical challenges in our industry today is accelerating this costly process. With advancements in artificial intelligence and computational biology, computational pharmacy is now playing an increasingly important role in modern drug discovery.

In this talk, Dr. Yuan will illustrate computational biology and artificial intelligence applications to answer fundamental questions in life science, especially in the area of G protein-coupled receptors (GPCRs). He will also discuss how to speed up modern drug discovery in an ultimately efficient way. Finally, Dr. Yuan will share his personal success story of developing “first-in-class” drug molecules and advancing them into clinical trials.

Current news

What's So Special About The 'Activity Spotter'? Detailed Insights Into SeeSAR's New Mode
April 29, 2026 10:22 CEST
SeeSAR’s Activity Spotter Mode is designed to dismantle the barrier of raw data and actionable SAR. It helps to answer the most relevant fields in hit-to-lead and lead optimization campaigns: 3D SAR and pharmacophore modeling. Which structural features in my molecule set are associated with activity? Which ones are linked...
Read on
Tool of the Month - FlexX
April 29, 2026 08:53 CEST
Spring is Molecular Docking Season The bread and butter of computational chemistry: predicting potential binding modes, which serves as a crucial foundation for SAR analysis and design decisions, is being made available to everyone this month with the proprietary docking tool FlexX. Validated by over 10,000 citations of its original...
Read on
The 95 Billion Update: Access the REAL Space
April 9, 2026 13:57 CEST
The latest update of Enamine’s REAL Space brings a new expansion, now featuring over 94.5 billion accessible, drug-like products, approaching the 100 billion mark. Built from 173 curated reaction protocols and 202,620 in-stock reagents and building blocks based on Enamine’s in-house knowledge, this version further enhances the world’s largest commercially...
Read on